Biochemical assessment of protein-calorie malnutrition in hepatic encephalopathy.
- Author:
Ji Sung CHUNG
1
;
Jin Il KIM
;
Se Hyun CHO
;
Soo Heon PARK
;
Joon Yeol HAN
;
Jae Kwang KIM
;
Young Sok LEE
;
Kyu Won CHUNG
;
Hee Sik SUN
Author Information
1. Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea. jyhan@catholic ac.kr
- Publication Type:Original Article
- Keywords:
Malnutrition;
Hepatic encephalopathy;
Insulin-like growth factor-1
- MeSH:
Carrier Proteins;
Fibronectins;
Fibrosis;
Growth Hormone;
Hepatic Encephalopathy*;
Hepatitis, Chronic;
Humans;
Insulin-Like Growth Factor I;
Leptin;
Liver Cirrhosis;
Liver Diseases;
Lymphocyte Count;
Malnutrition;
Nutritional Status;
Nutritional Support;
Prognosis;
Protein-Energy Malnutrition*;
Serum Albumin;
Vitamin A
- From:Korean Journal of Medicine
2006;70(6):650-655
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Most patients with hepatic encephalopathy have their protein intake restricted. Therefore, protein-calorie malnutrition becomes more severe and may cause more serious problems, such as infection and poor prognosis. The aim of this study is to determine better biochemical parameters for the assessment of nutritional status in patients with hepatic encephalopathy. METHODS: A total 109 patients (30 normal controls and 79 chronic hepatitis B) were enrolled. 79 patients were divided into three groups: chronic HBV infection (hepatitis group, n=28), liver cirrhosis without past history of hepatic encephalopathy (cirrhosis group, n=27), liver cirrhosis with present or past history of hepatic encephalopathy (encephalopathy group, n=24). Serum albumin, total lymphocyte count, IGF-1, growth hormone, retinol binding protein, leptin and fibronectin were measured. RESULTS: Serum albumin level, total lymphocyte count, IGF-1, and growth hormone were significantly lower in encephalopathy group than other groups (p<0.001, p=0.003, p<0.001, and p<0.001, respectively). However, RBP, leptin, and fibronectin were not different among the groups. The level of serum albumin and IGF-1 were significantly lower in encephalopathy group than cirrhosis group (p=0.002, p<0.001, respectively), but growth hormone was not significantly different between cirrhosis group and encephalopathy group. CONCLUSIONS: The level of serum albumin and IGF-1 may be important parameter for nutritional support in chronic liver disease, especially in patients with hepatic encephalopathy, because the level of serum albumin and IGF-1 relate with hepatic encephalopathy as well as reflect the progression of chronic liver disease.
